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Post-translational modifications of
actin affect its folding and structure,
as well as interaction with actin-bind-
ing proteins, and thus interfere with
cytoskeleton dynamics.
The actin N-terminal acetyltransferase,
NAA80, was recently identified, thus
solving a 30-year-old mystery on the
final step of actin’s unique and con-
served N-terminal maturation process.
Acetylation and arginylation compete
for actin’s N terminus, both affecting
filament formation, interaction with
actin-binding proteins, and cell
motility.
Actin oxidation of Met44 and Met47 by
the MICAL enzymes promotes, in
synergy with cofilin, the disassembly
of actin filaments and is linked to can-
cer development.
Toxin-mediated modifications of actin
may lead to actin filament aggregation,
and in some cases cell death.
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adrian.drazic@uib.no (A. Drazic).Actin is one of the most abundant proteins in eukaryotic cells and the main
component of the microfilament system. It plays essential roles in numerous
cellular activities, including muscle contraction, maintenance of cell integrity,
and motility, as well as transcriptional regulation. Besides interacting with
various actin-binding proteins (ABPs), proper actin function is regulated by
post-translational modifications (PTMs), such as acetylation, arginylation, oxi-
dation, and others. Here, we explain how actin PTMs can contribute to filament
formation and stability, and may have additional actin regulatory functions,
which potentially contribute to disease development.
The Fundamentals of Actin Functionality
Actin (see Glossary) accounts for up to 15% of the total protein level in muscle cells and 1–
3% in nonmuscle cells. It exists in both a monomeric globular state (G-actin) and polymerized
filamentous state (F-actin; Figure 1A), and the switch between the two states is highly dynamic.
The actin filaments play crucial roles in countless cellular functions, including muscle contrac-
tion, cell signaling, as well as cell integrity and motility [1]. The multifunctionality of actin is based
on three pillars (Figure 1B): chaperonin-assisted folding [2], interactions with actin-binding
proteins (ABPs) [1], and post-translational modifications (PTMs; Figure 1C) [3]. Numer-
ous studies and reviews describe the influence ABPs have on the actin cytoskeleton. In this
review, however, we describe the most recent findings on actin PTMs shedding light on a
crucial, but often overlooked, aspect of actin biology.
Actins represent a family of isoforms which are highly similar in sequence (93% sequence
identity) and each conserved throughout evolution. Based on their amino acid sequences, six
isoforms were described and classified according to the tissues in which they were found in
mammals and birds: four muscle forms; a-skeletal, a-cardiac, a-smooth, g-smooth, and two
nonmuscle cytoplasmic actins: b-cytoplasmic and g-cytoplasmic [4]. a, b, and g refer to their
respective mobility during isoelectric focusing, which is exclusively due to the number (3/4) and
nature (Asp/Glu) of the N-terminal acidic residues. For example, the N terminus of b-cytoplasmic
actin is Ac-DDDIAALVV- while that of g-cytoplasmic actin is Ac-EEEIAALVI-. The four underlined
residues constitute the only differences in a total of 375 residues present in these two isoforms,
emphasizing their conserved nature. Despite their sequence and structural similarities, actin
isoforms display both overlapping and unique cellular roles (reviewed in [5]). This has been clearly
demonstrated in mice where knockout of b-actin results in embryonic lethality [6,7], while g-actin-
deficient mice show developmental defects, but are viable [8,9]. Although these remarkably
different effects are not yet fully understood, it is known that these two isoactins display distinct
intracellular localization patterns [5]. Further in vitro experiments reveal that mixtures of isoactins in
filamentscould affectpolymerization dynamics, stability, and interactionswith ABPs [5,10]. On top
of these subtle differences, PTMs could contribute by affecting actin structure, localization, and
function. Most PTMs will affect the isoactins in a similar manner, given the actin sequence502 Trends in Biochemical Sciences, June 2019, Vol. 44, No. 6 https://doi.org/10.1016/j.tibs.2018.11.010
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Glossary
Actin: family of multifunctional
globular proteins that are able to
polymerize into filaments and interact
with a multitude of actin-binding
proteins. The family consists of at





ABPs are signaling pathway-
controlled actin interactors, which
regulate the polymerization and
depolymerization of actin filaments as
well as their organization in the
cytoskeleton network. Known ABPs
include: the Arp2/3 complex,
profilins, gelsolin, formins, and cofilin.
ATE1: arginyl-tRNA-protein
transferase 1 catalyzes the
attachment of arginine to the N
terminus of an acceptor protein or to
internal amino acid side chains.
Cytoskeleton: highly organized
protein network in all domains of life
(prokaryotes, archaea, and
eukaryotes), consisting of hundreds
of proteins which are interconnected
by filaments (actins), tubules
(tubulins), and the cytokeratin
network.
F-actin: polymeric, filamentous form
of actin.
G-actin: monomeric, globular form
of actin.
MICAL: MICALs (molecule
interacting with CasL) are cytosolic,
multidomain enzymes that belong to
a family featuring monooxygenase
activity. They reversibly oxidize
Met44 and Met47 of F-actin.
NAA80/NatH: Na-acetyltransferase
protein 80/N-terminal acetylation
complex H belong to the N-terminal
acetyltransferase (NAT) family that,
together with the NatB complex, are
involved in the unique N-terminal
maturation process of actin by
acetylating its N terminus. The NAT
enzyme family provides Nt-
acetylation for about 80% of the
human proteome.
Nt-acetylation: addition of an acetyl
group (Ac) to the N terminus of a
protein. Nt-acetylation is catalyzed by
N-terminal acetyltransferases using
acetyl-CoA as donor.
Nt-arginylation: addition of an
arginine residue (Arg/R) to the N-
terminus of a protein. Nt-arginylationsimilarities. However, as described later in this review, there are clear cases of isoform-specific
PTMs contributing to differentiated functions.
Post-translational Modifications: The Underrated Players of Actin
Cytoskeleton Dynamics
The first actin PTM, N-terminal (Nt) acetylation, was reported for skeletal muscle actin in 1966
by Gaetjens and Bárány [11], and later identified in all other actin isoforms. Today, more than
140 PTMs have been described in eukaryotic actin sequences ([3] and http://www.
phosphosite.org). Some actin PTMs are quantitative and reversible, whereas others are
rare, affecting only a minority of the molecules that make up the cellular actin pool. Thus,
many actin PTMs should be considered as partial modifications. Actin PTMs are found on 94
different side chains (Table 1, Key Table) which constitute about 45% of the residues that can
be modified. Specifically, new phosphorylation, ubiquitination, and SUMOylation sites have
been identified by global proteomics analyses in recent years [12–19]. Interestingly, we have
noticed regions where the frequency of PTMs is significantly lower than average (regions: 95–
145, 240–256, and 331–354). This follows the overall accessibility of the side chain residues
in the actin structure, though loss of ATP/ADP or internal cleavages could also induce partial
denaturation, resulting in unspecific low-level modifications. It is currently not clear to which
extent the latter contribute to actin’s cellular role, or whether they should be considered as
structural noise. Furthermore, our knowledge about the regulation, reversibility, and the
interplay between individual PTMs remains limited. Given the high number of reported actin
PTMs and the absence of detailed studies for most of them, we focus here predominantly on
recent reports covering Nt-acetylation, Nt-arginylation, and oxidation of actin. We dis-
cuss their molecular and physiological consequences, and their potential role in disease
development.
Structural and Regulatory Implications of Actin PTMs
Although not all actin PTMs appear at the same time on the same molecule, and some PTMs
have only been reported in particular organisms, their sheer number poses a serious challenge
for a global understanding of their regulatory mechanisms. For instance, how can an actin
molecule, whose primary role is to generate dynamic filaments composed of geometrically
conserved building blocks repeated over several thousand times, give rise to these structures
when decorated with potentially structure disturbing PTMs? How can both G- and F-actin
interact in a dynamic and rigorously controlled manner with a plethora of ABPs when carrying
this large number of modifications? PTMs can however participate in the structural architecture
of actin and modify their filaments. One of the best known examples is the structure of arthrin, a
55-kDa heavy form of actin first observed in insect muscle thin filaments [20]. This insect actin,
which is monoubiquitinated at Lys118 (Table 1), appears at every seventh subunit along the
filament long pitch helices. It was suggested that arthrin regulates muscle contractile activity
[20]. A more recent report on structural regulation of the actin filament network refers to Nt-
arginylation of b-actin by arginyl-tRNA protein transferase 1 (ATE1). In this case, Nt-arginylated
actins form normal filament structures. Non-Nt-arginylated actin isolated from ATE1 knockout
(KO) cells, on the other hand, forms bundles and aggregates, resulting in shorter filaments. On a
cellular level this leads to disorganization of lamellipodia and filopodia, an effect which is
attributed to altered interactions with ABPs [21].
Given the multifunctional nature of actin, one can expect that the final outcome of this high
number of PTMs could be extremely complex. Some PTMs will affect steady-state filament
growth by blocking one of the filament ends or reducing the concentration of polymerization
competent monomers. Some PTMs may interfere with the actin-ABP equilibrium or drive actinTrends in Biochemical Sciences, June 2019, Vol. 44, No. 6 503
is catalyzed by the arginyltransferase
ATE1 using arginyl-tRNA as donor.
N terminus: start of a protein or a
polypeptide, which has a free amino
group (-NH2). The amino group is
usually positively charged at
physiological pH (7.4). N-terminal
modifications will mask or change
this charge.
Post-translational modifications
(PTMs): protein modifications that
are added after the protein has been
fully translated and/or folded.
Modificationsolecules, such as
oxidation and acetylation, to the
addition of polypeptides such as
SUMOylation and ubiquitination.
ROS: reactive oxygen species are
highly reactive molecules and free
radicals derived from oxygen that
contributes to oxidative stress, which
leads to various diseases.molecules towards degradation pathways. And if this is not yet sufficiently complex, PTMs may
enhance or switch off each other’s effects by crosstalking mechanisms. The circuits that are
produced could function via loops that on their turn activate novel circuits. These quantum bits
of modifications are most likely not simply noise, but could push the cell following stochastic
mechanisms towards a reversible or irreversible destiny. For instance, Tyr53 can be a target for
phosphorylation, but also for nitration during oxidative stress. Similarly, Cys374 is highly
reactive and can accept different types of modifications (Table 1). It is not clear whether these
modifications will result in the same effect because they display a different chemical nature. An
interesting example of the complexity involves some prominent ABPs like ADF/cofilin, gelsolin
(Figure 1D), profilin, and DNase I (Figure 1E). Profilin binds to two regions in actin (Figure 1E),
while cofilin interacts with actin via three sites (Figure 1D) [1,22]. Part of these sites overlap with
each other. Thus, modifications in actin could tilt the balance by which these two ABPs exert
their control on actin assembly. N-terminal maturation of actin is an elegant example where a
particular protein modification depends on the previous one. Here, the successive actions of
methionine aminopeptidases, N-terminal acetyltransferases, and ATE1 result in most actin
molecules being Nt-acetylated, whereas a minority is Nt-arginylated (discussed later in this
review).
N-Terminal Processing of Actin: A Unique Maturation Mechanism
Actins are first synthesized as precursor molecules which are further N terminally processed by
successive actions of N-terminal acetyltransferases and aminopeptidases. This process was
first described by Redman and Rubenstein in the early 1980s [23], and only recently more
details on the players have become available. The six expressed mammalian actin isoforms are
divided into two categories based primarily on the nature of their unprocessed N-terminal
sequences (Figure 2A) [4]. For class I actins (nonmuscle b- and g-actin) the initiator methionine
(Met1) is directly followed by three acidic amino acids (MDDD-/MEEE-). The actin maturation
process begins when the nascent N terminus is cotranslationally Nt-acetylated by NatB, which
also acetylates other eukaryotic proteins beginning with MD-/ME- [26]. Normally, acetylation of
acidic N termini ensures that Met1 is retained, but in an unusual twist from nature’s side the Nt-
acetylated Met1 is removed by a still unidentified aminopeptidase. The neo-N terminus (DDD-/
EEE-) is then Nt-acetylated by the recently identified NAA80/NatH generating the mature actin
protein [27–29]. For class II actins (striated and smooth muscle actins) an additional cysteine
residue (MCD/E-) complicates the N-terminal processing. In this case, Met1 is cotranslationally
removed by methionine aminopeptidase followed by Nt-acetylation of the exposed cysteine,
presumably by NatA. Finally, an unknown aminopeptidase removes the acetylated cysteine
and the processed acidic N terminus is then reacetylated, most likely by NAA80 [27,28],
thereby completing the maturation process.
N-terminal actin maturation gained new attention when it was discovered that the processed N
terminus of b-actin (DDD-) can either be acetylated by NAA80 or arginylated by ATE1 [30]. Nt-
arginylation of b-actin is found to occur on Asp3 after the protein has undergone sequential
removal of both the first and second amino acid (RDD-) (Figure 2A) [30]. This modification profile
has not been observed on any other actin isoforms. However, it would be interesting to
understand why Asp3 is not further Nt-acetylated, which should be thermodynamically a more
favorable reaction over the arginylation step. A recent structural analysis indicates that DD-
starting actin forms a poor substrate for NAA80 [29]. Alternatively, subcellular variations in the
substrate concentrations, as well as the enzyme amounts and activities, could lead to local
competitions. Indeed, a recent study suggests that Nt-arginylated b-actin in mouse embryonic
fibroblast (MEF) cells is concentrated at the leading edge of lamellipodia, and is thus mainly
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Figure 1. Post-translational Modifications of Actin. (A) Actin can be present as free monomers called G-actin (red circles), or polymerize into microfilaments known
as F-actin (red chains). The switch between the two states is highly dynamic and partly regulated by post-translational modifications (PTMs). (B) The three pillars
supporting the multifunctionality of actin: chaperone-assisted folding, actin binding proteins, and PTMs. (C) Structural formulae of major actin PTMs. Actin molecules
can be post-translationally modified by, for example: methylation, acetylation, arginylation, SUMOylation, ubiquitination, ADP-ribosylation, methionine oxidation,
cysteine oxidation, phosphorylation, and tyrosine nitration (attachment shown in red). (D) and (E) b-actin structure (PDB: 2BTF) [85] showing ATP (magenta) and
selected amino acid residues (color code for atoms: carbon, green; nitrogen, blue; oxygen, red; cysteines, yellow) carrying PTMs. Interaction interfaces for (D) the
gelsolin subunits G1 and G3 (green box) and cofilin (burgundy box), as well as (E) DNase I (pink box) and profilin (blue box) are highlighted, demonstrating that many
amino acid residues that are part of these interfaces are subjects of modifications, and thus PTMs can interfere with ABP binding.
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Key Table
Table 1. Major Post-translational Modifications of Actin Where Modified Residues Are
Numbered According to Class I Actins (b/g-Actin)
Actin PTM Modified residuesa
Acetylation Met1, Asp2, Glu2, Cys2d, Asp3d, Lys50b, Lys52d, Lys61, Lys68, Lys113b, Lys191b, Lys193d, Lys213b, Lys315b, Lys326b, Lys328b
ADP-ribosylation Arg28c, Arg95c, Thr148b, Arg177b, Arg206c, Arg372c
Arginylation Asp3, Ser52b, Ser54d, Ile87b,d, Phe90, Gly152d, Leu295d, Asn299b,d
Carbonylation His40, His87b, His173, Cys374b
Crosslinking Lys50/Glu270b
Disulfide bond Cys285b, Cys374b
Glutathionylation Cys217b, Cys374b
Methylation Lys18b, Lys68b, His73b, Lys84, Ile87b,d, Asn299b,d, Lys326b,c
Tyrosine nitration Tyr53b, Tyr69b, Tyr91b, Tyr198b, Tyr218b, Tyr240b, Tyr294b, Tyr362b
S-nitrosylation Cys217b, Cys257b, Cys285b, Cys374b
Oxidation Cys17, Met44, Met47, Trp81d, Met82, Trp88d, Met178, Met190, Cys217b, Met227, Cys257b, Met269, Cys272b, Cys285b, Met235,
Trp342d, Met355, Trp358d, Cys374b
Phosphorylation Ser14, Ser33, Ser52b, Tyr53b, Ser60, Thr66, Tyr69b, Thr77, Thr89, Tyr91b, Tyr143, Thr148b, S155, Thr160, Thr162, Tyr166, Tyr169,
Thr186, Tyr198b, Ser199b, Thr201, Ser201d, Thr202, Thr203, Tyr218b, Thr229, Ser233, S235, Ser239, Tyr240b, Thr249, Thr262d, S265,
S271, Tyr294b, Thr297, S300, Tyr306, Thr318, Ser323, Thr324, Ser324c Tyr362b, Ser365
SUMOylation Lys61b, Lys68b, Lys84b, Lys113b, Lys284b, Lys291b, Lys315b, Lys326b, Lys328b
Ubiquitination Lys18b, Lys50b, Lys61b, Lys68b, Lys84b, Lys113b, Lys118c Lys191b, Lys213b, Lys215, Lys238, Lys284b, Lys291b, Lys315b, Lys326b,
Lys328b, Lys359
aHighlighted in bold: amino acid modifications described in this review.
bAmino acid resides known to be modified by two or more PTMs.
cOnly described in non-mammalian actins.
dModified residues that are observed in class II actins (a-cardiac, a-smooth, a-skeletal, and g-smooth) where the N terminus starts with MC-.aggregates in vitro, while ATE1 KO cells show impaired lamella formation and cell migration
(Figure 2B) [30]. Acetylation enhances the negative nature of the N terminus, by neutralizing the
free a-amino group, while arginylation on the other hand decreases the negative charge
density. It is therefore not surprising that both modifications play a role in cytoskeleton
morphology and affect actin’s polymerization kinetics [27,30]. NAA80 specifically Nt-acetylates
b- and g-actin, and presumably also acetylates the N terminus of class II actins [27–29].
Furthermore, NAA80’s activity regulates actin cytoskeleton dynamics and cell morphology by
reducing actin filament assembly as well as filopodia and lamellipodia formation, which
ultimately decelerates cell migration (Figure 2B) [27,32]. Most of the data on actin’s structure
reveal large fluctuations in the N terminus (amino acid residues 1–6), indicating disorder. The
Nt-acetylation effect observed on actin filament elongation is therefore difficult to explain. The N
terminus is also not positioned in close proximity to the monomer–monomer interface, making a
direct effect less likely. However, the introduction of conformational changes cannot be
excluded. Most likely the effect is induced by contacts with ABPs, since the N terminus of
both monomeric and filamentous actin is exposed on the surface where it can interact with a
number of regulatory proteins, such as myosin [33], and potentially formins [27,34]. Indeed,
early studies on genetically engineered yeast actin demonstrated that the negative nature of
actin’s N terminus enhances the activation of myosin’s ATPase activity [35].506 Trends in Biochemical Sciences, June 2019, Vol. 44, No. 6
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Figure 2. Actin’s Unique N-Terminal Maturation Process and Functional Consequences of Nt-Modifications on the Actin Cytoskeleton. (A) Actins are
first synthesized as precursor molecules which are rarely detected in their native state owing to a unique N-terminal maturation process. For class I actins (b/g-actin) the
nascent N termini are cotranslationally acetylated by NatB, followed by removal of the acetylated Met1 by a still unidentified aminopeptidase (AP). Finally, the newly
exposed acidic N termini (DDD-/EEE-) are acetylated by NAA80/NatH (Ac-DDD-/Ac-EEE-). A few b-actin N termini will not be Nt-acetylated, instead they undergo
further proteolytic processing, and the new N termini (DD-) are then Nt-arginylated by arginyl-tRNA protein transferase 1 (ATE1) (RDD-). In the case of class II actins
(a-actins and g-smooth muscle actin), methionine aminopeptidase (MetAP) removes Met1 at the ribosome followed by acetylation of Cys2 presumably by NatA (Ac-CD/
E-). Subsequently, the acetylated Cys residue is removed by an unknown aminopeptidase and the resulting acidic N terminus is finally acetylated by NAA80 (Ac-D/E-).
(B) Acetylation and arginylation (top) changes the N-terminal charge density and affects actin structure and function. In the absence of NAA80-mediated acetylation of
actin’s N terminus (middle), actin filament elongation and depolymerization are accelerated. Moreover, NAA80 HAP1 knockout cells show increased lamellipodia and
filopodia formation, and compared to control cells have increased cell motility, as shown by scratch wound assay and chemotaxis migration. Consequently, NAA80 acts
as a natural brake for cell movement. Nt-arginylation prevents actin from aggregating in vitro (bottom). ATE1 knockout mouse embryonic fibroblasts (MEFs) appear
smaller than control cells, and fail to form normal lamella, causing impaired cell movement. ATE1 is thought to regulate active migration at the leading edge. Ac, acetyl;
R, arginine.
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Stressed Actin: A Regulatory Pathway
For a long time, actin modifications caused by oxidative stress were considered to be
exclusively destructive. Oxidative stress is caused by reactive oxygen species (ROS;
Figure 3A), including: hydrogen peroxide (H2O2), hypochlorous acid (HOCl), and reactive nitrogen
species (RNS), such as nitric oxide (NO). ROS are byproducts of physiological redox regulation,
but are also actively produced by neutrophils of the innate immune system [36]. At low ROS
concentrations the thiol groups (SH) of cysteines can be oxidized to sulfenic acid or be gluta-
thionylated (Figure 3B,C). These modifications can be reversed by redox proteins, such as
thioredoxin and glutaredoxin. Moreover, the accessible methionine residues can be reversibly
oxidized to two methionine sulfoxide diastereomers (Met-S-SO and Met-R-SO; Figure 3C). Met-
(S/R)-SO can be reduced in humans by four stereoselective methionine sulfoxide reductases: one
MsrA, and three MsrBs (B1, B2, B3) [37]. It should be noted that the oxidation of Met to Met–SO
converts its hydrophobic side chain into a hydrophilic moiety. Consequently, the oxidation/
reduction process could have a profound effect on actin’s structures and ABP-interactions.
Oxidative stress further leads to the formation of disulfide bridges or mixed disulfide bonds with
glutathione (Figure 3C). The most vulnerable target in actin is Cys374, which can form an
intramolecular disulfide bond with Cys285 (Figure 3B), the latter causing delayed dissociation
between actin and spectrin [38,39], and reduced actin filament dynamics [40]. However, S-
glutathionylation of Cys374 appears crucial for the disassembly of the actomyosin complex, thus
promoting contraction of the cytoskeleton during cell spreading and the formation of stress fibers
[41]. H2O2/HOCl mainly target accessible cysteine and methionine residues in G-actin, (Cys272,
Cys285, Cys374, Met44, Met47, Met190, Met227, Met269, and Met355), which are more
solvent-exposed than others (Figure 3B), especially when not buried inside actin filaments
[42]. When applying high ROS concentrations, cysteine and methionine residues can become
irreversibly modified (sulfinic and sulfonic acid, and methionine sulfone). In addition, new mod-
ifications occur, such as tyrosine nitration (Tyr294) [43] and histidine carbonylation (His40, His87,
and His173) [38,44,45]. These modifications usually impair actin polymerization and destabilize F-
actin bundles [40,46]. Especially in the case of severe oxidative stress, actin carbonylation
accumulates and leads to aggregation ofactin [47]. Consequently, these irreversiblemodifications
inhibit cell proliferation, motility, and reduce cell viability. It is noteworthy that the many studies that
identified actin modifications upon ROS treatment were performed in vitro, and thus the physio-
logical relevance is not always obvious.
Despite their destructive nature, ROS have in recent years been shown to act as signaling
molecules under physiological conditions, and their induced modifications are key regulators in
certain cellular pathways. MICAL-mediated methionine oxidation was discovered to initiate F-
actin depolymerization [48]. The MICAL enzymes belong to the class of flavoprotein mono-
oxygenases, using NADPH and H2O2 to stereoselectively oxidize Met44 and Met47 (Met44/47)
of actin to Met-R-SO [48–50]. MICALs bind directly to F-actin, enhancing its catalytic activity
[48,51]. The oxidation of Met44/47, which depends on the ADP/ATP nucleotide-binding state
of F-actin, destabilizes actin filaments and initiates their disassembly. It further causes confor-
mational changes of F-actin, which increases the susceptibility for cofilin (an F-actin depoly-
merizing factor), and thus accelerates filament disassembly (Figure 3D) [52].
Another signaling molecule, NO, which is enzymatically generated by the endothelial nitric oxide
synthase (eNOS), has important functions in T-cell regulation and activation [53]. eNOS
colocalizes with F-actin near the Golgi, and modifies Cys374 by S-nitrosylation. This impairs
binding to profilin-1, resulting in reduced actin polymerization and relocalization inside the cell
(Figure 3E) [54]. These examples demonstrate the importance of actin oxidation as a regulatory
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ROS-Mediated Actin Modifications and Regulation by MICAL Enzymes. (A) Reactive oxygen species (ROS) are products of redox reactions and are
generated when molecular oxygen (O2) is not completely reduced to water (H2O), resulting in superoxide (O2
), hydrogen peroxide (H2O2), and hydroxyl radicals (∙OH).
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Physiological Consequences of Actin PTMs
Actin PTMs play a central role in many biological processes, including neurodevelopment. Neurons
have an elaborate network of actin filaments, especially in dendritic spines and growth cones.
Dynamic phosphorylation of Tyr53 regulates F-actin turnover rates by destabilizing long actin
filaments. Moreover, it promotes the stability of shorter actin filaments, which facilitates a faster
reorganization of the cytoskeleton in dendritic spine maturation [55], a process crucial for learning and
memory formation. Neuronal development also depends on the activity of NADPH oxidase 2 (Nox2),
which regulates the distribution of H2O2 in neurons [56]. Nox2 colocalizes with F-actin bundles in the
peripheryofneuronalgrowthconeswhere itsH2O2-producingactivity regulatesF-actindynamicsand
neurite outgrowth [57]. Furthermore, ATE1 was recently shown to be crucial for normal neuronal
outgrowth and migration in mice [58]. It was suggested that ATE1’s role in brain development arises
from cotargeting of ATE1 and b-actin mRNAs to the growth cones, resulting in a local synthesis of
arginylated b-actin that regulates neurite outgrowth. Moreover, ATE1-/-mice die during embryogen-
esis, most likely due to defective heart and vascular development [59]. The exact underlying molecular
mechanism(s) for the role of arginylation in cell motility [30], embryogenesis [59], and tissue develop-
ment [58,60] is not completely understood, given that ATE1 has more than one protein target.
Actin PTMs are also essential for effective cytokinesis and proper cell division. The dioxygenase
ALKBH4 localizes to the contractile ring where it demethylates K84me1 of actin, thus creating a
binding site for nonmuscle myosin II. ALKBH4-deficient cells display defective cleavage furrow
organization, resulting in cytokinesis failure and formation of multinucleated cells [61]. After
cleavage furrow ingression and midbody formation, actin must be cleared from the abscission
site to enable membrane scission by the ESCRT machinery. This is achieved by GTPase Rab35
activation of MICAL1, which is then recruited to the abscission site where it promotes rapid
depolymerization of F-actin from both ends, leading to an efficient clearing of F-actin [62].
Cytoskeletal reorganization can be also initiated by the Abl kinase, which phosphorylates the
Tyr500 ofMICAL1, enhancing its activity [63]. Since the Abl kinase respondsto a numberofstimuli,
such as the semaphorin/plexin complex, or the growth factors EFG and PDGF, MICAL activation
and subsequent actin oxidation has a broad spectrum of physiological consequences [64,65].
Actin shuttles between the cytoplasm and nucleus in an ABP-dependent manner. In the
nucleus, actin is thought to facilitate chromatin remodeling and gene transcription. MICAL2
induces F-actin depolymerization in the nucleus, enabling newly restored G-actin to act as a
transcriptional regulator in serum response factor signaling [66]. Moreover, nuclear actin can be
SUMOylated in a process that requires Lys68 and Lys284 [67,68]. It has been speculated that
SUMOylation regulates nuclear trafficking and actin structure [67].
Due to actin’s abundance and role in muscle cells, it is not surprising that actin PTMs participate in
the contractile machinery by modulating the electrostatic interactions between F-actin, tropomy-
osin, and myosin. For example, acetylation of Lys326 and Lys328 masks positive charges that are
crucial for proper thin filament regulation [69,70]. Expression of pseudo-acetylated cardiac actinHypochlorite acid is actively produced by the enzyme myeloperoxidase in neutrophils of the innate immune system as defense mechanisms towards invading
pathogens. (B) b-actin structure (PDB: 2BTF) [85] highlighting surface exposed Cys, Met, His, and Tyr residues that are susceptible towards ROS-mediated
modifications. (C) ROS target mainly Cys and Met residues of actin in a concentration-dependent manner, resulting in a variety of PTMs (disulfide bond formation,
nitrosylation, glutathionylation, multilevel cysteine oxidation, and stereoselective methionine oxidation). Most of these PTMs are reversed by redox enzymes (Trx,
thioredoxin; Grx, glutaredoxin; MsrA, methionine sulfoxide reductase A; MsrB, methionine sulfoxide reductase B). High ROS concentrations lead to irreversible
modifications (sulfinic and sulfonic Cys oxidation, Met sulfone). (D) MICAL enzymes bind to F-actin and catalyze in an NADPH-dependent reaction the oxidation of
Met44 and Met47 to Met-R-SO, initiating depolymerization. In addition, this attracts the F-actin severing protein cofilin, thereby accelerating the depolymerization effect.
Met-R-SO can be reduced to Met by MsrB, which allows actin to enter a new polymerization cycle. (E) Nitric oxide (NO) is involved in T-cell regulation and activation.
eNOS S-nitrosylates Cys374 of actin, impairing profilin-1 binding, and thus reducing actin polymerization rates.
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(K326Q, K328Q, and K326Q/K328Q) in indirect flight muscles of Drosophila melanogaster leads
to perturbed muscle structure and function as well as disrupting flight performance [71]. Masking
of Lys326 and Lys328 is thought to alter the electrostatic interactions with tropomyosin (Glu181)
and/or myosin (Glu286), destabilize the inhibitory positioning of tropomyosin, and thereby
enhance actomyosin formation causing muscle hypercontractility [71]. Actin acetylation might
therefore be crucial for proper muscle function. Indeed, the K328Q actin mutation causes
nemaline myopathy with muscle stiffness and hypertonia [72].
The Role of Actin PTMs in Diseases
The actin cytoskeleton has an indisputable role in human development and failure to orches-
trate the dynamic interplay between actin and ABPs could lead to actin-related diseases, a
concept which was further elaborated by Rubenstein and Wen (Box 1) [73]. They described a
regulatory allosteric system in human actins that appear prone to disease-causing mutations.
Some of the most effective mutations colocalize with a PTM hotspot in an otherwise poorly
modified region. We therefore suggest similar molecular pathophysiology upon dysfunctional
actin modifications, especially with regard to ABP interactions (Box 1).
Abnormal cell invasion and metastasis is a hallmark of cancer, two processes in which the actin
cytoskeleton plays a dominant role. Therefore, it is not surprising that actin PTMs have been linked
to cancer development and tumorigenesis. Both NAA80 and ATE1 KO cells display defective cell
motility [27,30], which is a common feature among cancer cells and contributes to invasion and
metastasis. Reduced ATE1 expression has been reported in various human cancers [74].
Moreover, ATE1 KO MEFs exhibit defective contact inhibition which is thought to support the
uncontrolled growth in dense cultures and invasive behavior in Matrigels [74]. The direct tumori-
genic potential of NAA80-deficient cells has yet to be investigated. Nevertheless, several somatic
mutations in NAA80 and ATE1 are reported in the COSMIC cancer database (v86, released 14
Aug 2018) [75]. For example, the mutation profile of NAA80 in human cancers includes 45
missense mutations and two frameshift mutations that, as far as we know, have not been
characterized. The frameshift deletion mutation p.E92fs*5 (resulting in 92 out of 308 amino acid
residues) should, in theory, give rise to a catalytic-inactive form of NAA80. Furthermore, several of
the residues that are affected by missense mutations (W105R, R107H, R112H, F123S, G190D,
L194Q, P258A, P266L, P267S, P283L, G298W, and I308M) are evolutionarily conserved,
implying that these residues may be important for NAA80’s structure and function [29]. It is
currently not known whether any of these NAA80 mutations have disease-causing effect(s). But
one could speculate that some of them affect NAA80’s activity and actin Nt-acetylation, thus
altering cytoskeleton dynamics and promoting tumor progression.
The emerging role of the MICAL enzyme family in F-actin disassembly, a key element of cell
motility and migration, has placed the MICALs at the new horizon of cancer research. MICAL1
expression was directly linked to increased cell migration and invasiveness in various melanoma
and breast cancer models [76–78]. ROS production by MICAL1, which promotes epithelial–
mesenchymal transition (EMT), and thus metastasis formation, was linked to typical EMT-
dependent signaling cascades, such as semaphorin/plexin [76] and Rab35 signaling, as well as
the PI3K/AKT pathway [77] and the EGF-induced MAPK/ERK pathway [78]. Regulation of EMT
was also linked to MICAL2 expression. Gastric and renal epithelial cancer cells show an
increase in EMT upon MICAL2 expression, and a reduced viability, motility, and invasiveness
when MICAL2 is depleted from these cells [79].
Actin PTMs also play exceptional roles in the development of infectious diseases. Several
bacterial pathogens release toxins that induce ADP-ribosylation and crosslinking, of actin,Trends in Biochemical Sciences, June 2019, Vol. 44, No. 6 511
Box 1. Pathogenic Actin Allosteric Regulatory System: A New Concept
Bartlett, Rubenstein, and their colleagues, hypothesized the existence of a pathogenic actin allosteric regulatory system
where the binding of ABPs initiates conformational changes in structural networks, affecting actin filament formation and
stability [73,86,87]. Central to the hypothesis is actin’s pathogenic helix (Lys113–Thr126), which extends from the
filament surface to the strand–strand interphase, and the C-terminal helix (Val370–Phe375; Figure I). The two helixes are
interconnected via interactions between Glu117 and His371. Moreover, Lys113 in the pathogenic helix extends towards
the actin–actin interface where it forms an ionic bridge with Glu195 of an actin subunit in the opposing strand. This
filament-stabilizing interaction is modulated by Arg256 on the cross-strand monomer, giving rise to a triangular unit.
Together, these interacting structural elements are thought to constitute an allosteric system where surface binding of
ABPs may induce conformational changes that propagate throughout the actin molecule and affect filament dynamics.
The pathogenic helix is a mutational hotspot and implicated in several actinopathies, including nemaline myopathy,
Baraitser–Winter syndrome, and deafness (reviewed in [73]). For example, two missense mutations in g-actin (K118M
and K118N) can give rise to nonsyndromic deafness. A study using yeast actin revealed that both mutations affect the
structure and function of the DNase I binding loop, and in the case of K118N resulted in faster filament formation [88].
The K113E mutation in a-actin is associated with nemaline myopathy [89] and was recently reported to suppress actin
catch-slip bonds [90]. In yeast, expression of K113E actin leads to growth defects and defective actin polymerization
[91]. Within the broad repertoire of actin PTMs we notice that both Lys113 and Lys118, which are members of the
pathogenic helix, are located within a region that is highly PTM silent. Residues 96–142 do not carry PTMs, except for
Lys113 which can undergo acetylation, SUMOylation, or ubiquitination. We assume that unintended Lys113 modifica-
tions could induce effects similar to the different phenotypes described for the mutations at this site. Another example is
Cys257, which is highly susceptible to ROS-induced modifications [3]. Missense mutations in the neighboring residue
Arg256 are implicated in several diseases [73]. Interestingly, different mutations of Arg256 cause various symptoms
where R256C and R256H are associated with TAAD aneurysms, while only the R256C mutation causes cerebral
aneurysms. Finally, we note that several residues within the C-terminal helix are modified, including Cys374 which is
highly reactive. Together, these effects emphasize the functional importance of this region for proper actin function.
Monomer 2
Monomer 1
Figure I. Actin’s Pathogenic Helix. Shown is a model structure of two a-skeletal actin monomers (PDB: 2ZWH) [92].
The interaction between two protomers in an actin filament is dependent on the pathogenic helix (magenta, Lys113–
Thr126) and the C-terminal helix (orange, Ala365–Phe375) of monomer 1 (cyan), and the residues Glu195 (red spheres)
and Arg256 (pink spheres) of monomer 2 (green).which interfere with the host cells’ ability to polymerize actin (Box 2). Although other toxic
effectors are secreted by pathogens into the host cell, the actin-modifying toxins take a key role
in altering the host cell cytoskeleton to the advantage of the pathogen (Box 2).
Competition for Actin’s N Terminus: Nt-Acetylation versus Nt-Arginylation
Nt-arginylation was only reported for b-, but not g-actin, in which the DDD-actin N-terminal
sequence was converted into an RDD-actin sequence, turning a 3 charged N terminus512 Trends in Biochemical Sciences, June 2019, Vol. 44, No. 6
Box 2. Bacterial Pathogens Cause ‘Toxic’ Actin Modifications
Many human pathogens (bacteria, parasites, etc.) deploy their pathogenic properties by secreting toxins into host cells
via various delivery systems. These bacterial effectors are usually multiprotein complexes and exert their toxicity by
targeting vital host complexes including signaling pathways, ribosomes, membrane trafficking, and the actin cytoske-
leton (reviewed in [93]). A typical way how toxins affect actin is by modifying certain residues to change host cell behavior
in favor of the pathogen, or even causing cell death. In particular, ADP-ribosylation (Figure I) is a toxin-linked actin
modification, which is catalyzed by enzymes called ADP-ribosyltransferases (ART). ADP-ribosylation of G-actin at
Arg177 by the Clostridium botulinum C2 toxin inhibits actin polymerization, ATP binding, and ATPase activity [94,95].
This toxin seems to prefer cytosolic b/g-actin, however a-actin is also a potential target [93,96]. In contrast, ADP-
ribosylation at Thr148 by the Photorhabdus luminescens toxin (TccC3) leads to polymerization of long, curled filaments,
and consequently to actin aggregation. It further impairs the binding of actin severing proteins, such as gelsolin and
ADF/cofilin, and reduces ATPase activity [97]. Thus, actin ADP-ribosylation inhibits various cellular functions, such as
phagocytosis by the innate immune system, the first defense line against evading pathogens [98]. Another mechanism
of pathogenic actin effectors is intermolecular crosslinking of actin molecules and thus impairment of their function. One
of these toxins is the actin crosslinking domain (ACD) produced among others by the Vibrio species (known
representative Vibrio cholerae), which crosslinks actin molecules at Lys50 and Glu270 generating nonfunctional actin
oligomers. The toxicity of these actin oligomers is partially due to their ability to hijack formins [99] and various actin
assembly factors [100], resulting in decreased nucleation and elongation abilities of these ABPs, and thus decreased
actin polymerization in cells. The Legionella pneumophila effector protein RavK deploys a different strategy to disrupt the
actin cytoskeleton. It does not add a new chemical group to one of the actin residues; instead it cleaves actin between
the amino residues Thr351 and Phe352 thereby inhibiting actin polymerization and modulating the host’s actin
cytoskeleton [101].
ADP-ribosyla on
Figure I. Chemical Identity of ADP-Ribose. ADP-ribose (highlighted in red) is mainly known to be attached to actin
by bacterial toxins in a reaction called ADP-ribosylation. The toxins target arginine and threonine residues, and therby
impair actin functionality.into an uncharged entity [30]. The absence of a similar modification of g-actin (starting with
EEE-) was later attributed to fast degradation of the modified isoform via the ubiquitination
pathway, owing to slower translation rates thereby exposing a crucial lysine residue [80].
This finding caused high interest in the field because it was stated that approximately 40%
of intracellular b-actin could be Nt-arginylated in MEFs [30], while no such modification was
ever reported in b-actin purified by DNase I affinity chromatography from lysates of non-
muscle cells or from various tissues. Later reports of the same group confirmed the
existence of Nt-arginylation of b-actin, though at much lower levels [31]. Additional argi-
nylation sites were later detected following high resolution mass analysis on total cellular
lysates [81]. Interestingly these were not only limited to N-terminal residues, but also
happened at midchain side chains [82]. The assumed enzymatic mechanisms, in which
each time the participation of the same players: arginyl-tRNA and the corresponding
transferase ATE1, was noticed, should be completely different. While the reaction at the
N terminus follows the same mechanism of the ribosomal peptidyl transferase reaction
forming a peptide bond, the proposed mechanism for midchain arginylation is thought to
pass via the formation of an intermediate carboxylic anhydride which is then attacked by the
a-amino group of arginine. The latter mechanism has at least two difficult points: firstly, theTrends in Biochemical Sciences, June 2019, Vol. 44, No. 6 513
Outstanding Questions
Which enzyme catalyzes the removal
of the Nt-acetylated initiator methio-
nine in class I actins and/or the Nt-
acetylated cysteine in class II actins?
This unknown N-acetyl aminopepti-
dase is the last missing link to the N-
terminal processing of actin. Why does
actin have such a complex, and from
an evolutionary point of view late devel-
oped maturation process? Is it a qual-
ity control mechanism, as most mature
actins molecules exist in the Nt-acety-
lated form? But how, when, and where
does the aminopeptidase, NAA80 and
ATE1 interact and perform their activity
in the cell?
Is Nt-arginylation of actin a general
mechanism of cytoskeletal regulation?
Does it occur in all cells and tissues, or
is it specific to distinct subtypes of cells
or cellular conditions? How does the
cell decide if b-actin should be Nt-argi-
nylated or not?
The importance of MICAL-catalyzed
actin oxidation is thought to be clear:
Met44/47 of actin are conserved from
invertebrates to humans; MICALs are
expressed in all organs and tissues;
and several MICAL knockdown stud-
ies have demonstrated its crucial role
in immune cells, skeletal muscle func-
tion, and metastasizing cancer cells.
But why are there different MICAL iso-
forms (three main isoforms in
humans)? Is it specific regulation or
localization? Does MICAL activity play
a role in muscle cell contraction?
Which of the different actin PTMs
occur simultaneously? How do these
PTMs interact with each other? Can
they occur in parallel, resulting in a fine
regulation of actin function, including
differential ABP binding? Or are they
mutually exclusive, as is the case for
Nt-acetylation and Nt-arginylation?
Middle-down proteomics, using endo-
proteinases, such as GluC (instead ofsame enzyme ATE1 should catalyze two completely different mechanisms, and secondly,
the supposed formation of the intermediate anhydride needs much more energy than can
be delivered by the cleavage of the aminoacyl bond in the arginyl-tRNA [82]. Additional
elegant MS techniques revealed prominent arginylation of a-cardiac actin during heart
development [82,83]. Four sites were identified: Ser54, Ile87, Gly152, and Leu295.
Although these modifications might be substoichiometric, where only a few actin molecules
are affected, in the particular case of polymerizing actin they could have a profound effect
on the cellular organization of the myofibrillar/microfilament system, with functional impli-
cations. Indeed, in the current models of actin polymerization and branching, one modified
actin monomer among a thousand intact actins could affect the final picture, by functioning
either as F-actin capping entity or as initiation  site for filament branching [30,84].
Concluding Remarks
Actin is a remarkable protein, both in terms of its evolutionary conservation and multifunction-
ality. A combination of factors is responsible for its extraordinary biological capacity. While
ABPs have received considerable attention for regulating the actin cytoskeleton, numerous
PTMs have lately entered the spotlight as important influencers for proper actin function,
including acetylation, arginylation, and oxidation. Although new details about the impact of
PTMs on actin became available in recent years, many questions remain. By uncovering NAA80
as actin’s N-terminal acetyltransferase the field has taken a crucial step towards deciphering
the complete maturation pathway of mammalian actins. Still, the identity of the N-terminal
aminopeptidase that specifically acts on actin remains unknown. Another intriguing concept is
the functionality of the different actin isoforms. To what extent do their roles overlap, and when,
where, and how do they undertake their unique tasks? Related to this, how exclusive is the N
terminus of actin? Are the actions of the actin modifiers NAA80 and ATE1 mutually exclusive or
do they have tissue specific roles (see Outstanding Questions)? A potential synergy between a
plethora of actin PTMs could possibly revolutionize our understanding of actin cytoskeleton
dynamics. One of the major challenges within actin research is to differentiate between the
different actin isoforms. This hurdle has become increasingly apparent as PTMs might affect
actin isoforms differently. Given actin’s pathophysiological role, mapping actin’s modification
repertoire and defining the actin processing machinery and ABP interactome will be of great
basic and translational importance.
Acknowledgments
S.V. was supported by the Research Council of Norway through a FRIPRO mobility grant 261981, which is cofunded by
the European Union’s Seventh Framework Programme under Marie Curie grant agreement number 608695. A.D. was
supported by the Research Council of Norway project 249843.
Disclaimer Statement
The authors declare no competing financial interests.
References
trypsin) which generate larger poly-
peptides (5–7 kDa) for MS analysis,
have emerged as a new avenue for
identifying coexisting PTMs, and can
be used to study actin at different cel-
lular stages and conditions.1. Pollard, T.D. (2016) Actin and actin-binding proteins. Cold Spring
Harb. Perspect. Biol. 8, a018226
2. Balchin, D. et al. (2018) Pathway of actin folding directed by the
eukaryotic chaperonin TRiC. Cell 174, 1507–1521
3. Terman, J.R. and Kashina, A. (2013) Post-translational modifica-
tion and regulation of actin. Curr. Opin. Cell Biol. 25, 30–38
4. Vandekerckhove, J. and Weber, K. (1978) At least six different
actins are expressed in a higher mammal: analysis based on the
amino-acid sequence of the amino-terminal tryptic peptide. J.
Mol. Biol. 126, 783–802
5. Perrin, B.J. and Ervasti, J.M. (2010) The actin gene family: func-
tion follows isoform. Cytoskeleton 67, 630–634514 Trends in Biochemical Sciences, June 2019, Vol. 44, No. 66. Shawlot, W. et al. (1998) Restricted b-galactosidase expression of a
hygromycin-lacZ gene targeted to the b-actin locus and embryonic
lethality of b-actin mutant mice. Transgenic Res. 7, 95–103
7. Shmerling, D. et al. (2005) Strong and ubiquitous expression of
transgenes targeted into the b-actin locus by Cre/lox cassette
replacement. Genesis 42, 229–235
8. Belyantseva, I.A. et al. (2009) g-Actin is required for cytoskeletal
maintenance but not development. Proc. Natl. Acad. Sci. U. S. A.
106, 9703–9708
9. Bunnell, T.M. and Ervasti, J.M. (2010) Delayed embryonic devel-
opment and impaired cell growth and survival in Actg1 null mice.
Cytoskeleton 67, 564–572
10. Bergeron, S.E. et al. (2010) Ion-dependent polymerization differ-
ences between mammalian b- and g-nonmuscle actin isoforms.
J. Biol. Chem. 285, 16087–16095
11. Gaetjens, E. and Bárány, M. (1966) N-acetylaspartic acid in G-
actin. Biochim. Biophys. Acta 117, 176–183
12. Mertins, P. et al. (2014) Ischemia in tumors induces early and
sustained phosphorylation changes in stress kinase pathways
but does not affect global protein levels. Mol. Cell. Proteomics 13,
1690–1704
13. Mertins, P. et al. (2016) Proteogenomics connects somatic muta-
tions to signalling in breast cancer. Nature 534, 55–62
14. Tsai, C.F. et al. (2015) Large-scale determination of absolute
phosphorylation stoichiometries in human cells by motif-targeting
quantitative proteomics. Nat. Commun. 6, 6622
15. Lumpkin, R.J. et al. (2017) Site-specific identification and quanti-
tation of endogenous SUMO modifications under native condi-
tions. Nat. Commun. 8, 1171
16. Lundby, A. et al. (2012) Proteomic analysis of lysine acetylation
sites in rat tissues reveals organ specificity and subcellular pat-
terns. Cell Rep. 2, 419–431
17. Hendriks, I.A. et al. (2014) Uncovering global SUMOylation sig-
naling networks in a site-specific manner. Nat. Struct. Mol. Biol.
21, 927–936
18. Impens, F. et al. (2014) Mapping of SUMO sites and analysis of
SUMOylation changes induced by external stimuli. Proc. Natl.
Acad. Sci. U. S. A. 111, 12432–12437
19. Rolland, D. et al. (2014) Global phosphoproteomic profiling
reveals distinct signatures in B-cell non-Hodgkin lymphomas.
Am. J. Pathol. 184, 1331–1342
20. Bullard, B. et al. (1985) Arthrin: a new actin-like protein in insect
flight muscle. J. Mol. Biol. 182, 443–454
21. Saha, S. et al. (2010) Arginylation regulates intracellular actin
polymer level by modulating actin properties and binding of
capping and severing proteins. Mol. Biol. Cell 21, 1350–1361
22. Tanaka, K. et al. (2018) Structural basis for cofilin binding and
actin filament disassembly. Nat. Commun. 9, 1860
23. Redman, K. and Rubenstein, P.A. (1981) NH2-terminal process-
ing of Dictyostelium discoideum actin in vitro. J. Biol. Chem. 256,
13226–13229
26. Van Damme, P. et al. (2012) N-terminal acetylome analyses and
functional insights of the N-terminal acetyltransferase NatB. Proc.
Natl. Acad. Sci. U. S. A. 109, 12449–12454
27. Drazic, A. et al. (2018) NAA80 is actin’s N-terminal acetyltrans-
ferase and regulates cytoskeleton assembly and cell motility.
Proc. Natl. Acad. Sci. U. S. A. 115, 4399–4404
28. Wiame, E. et al. (2018) NAT6 acetylates the N-terminus of differ-
ent forms of actin. FEBS J. 285, 3299–3316
29. Goris, M. et al. (2018) Structural determinants and cellular envi-
ronment define processed actin as the sole substrate of the N-
terminal acetyltransferase NAA80. Proc. Natl. Acad. Sci. U. S. A.
115, 4405–4410
30. Karakozova, M. et al. (2006) Arginylation of b-actin regulates actin
cytoskeleton and cell motility. Science 313, 192–196
31. Pavlyk, I. et al. (2018) Rapid and dynamic arginylation of the
leading edge b-actin is required for cell migration. Traffic 19,
263–272
32. Aksnes, H. et al. (2018) Actin polymerization and cell motility are
affected by NAA80-mediated posttranslational N-terminal acety-
lation of actin. Commun. Integr. Biol. 11, e1526572
33. Sutoh, K. et al. (1991) Site-directed mutations of Dictyostelium
actin: disruption of a negative charge cluster at the N terminus.
Proc. Natl. Acad. Sci. U. S. A. 88, 7711–7714
34. Otomo, T. et al. (2005) Structural basis of actin filament nucleation
and processive capping by a formin homology 2 domain. Nature
433, 488–494
35. Cook, R.K. et al. (1993) Enhanced stimulation of myosin subfrag-
ment 1 ATPase activity by addition of negatively charged residues
to the yeast actin NH2 terminus. J. Biol. Chem. 268, 2410–241536. Schieber, M. and Chandel, N.S. (2014) ROS function in redox
signaling and oxidative stress. Curr. Biol. 24, R453–R462
37. Drazic, A. and Winter, J. (2014) The physiological role of reversible
methionine oxidation. Biochim. Biophys. Acta 1844, 1367–1382
38. Fedorova, M. et al. (2009) Reversible and irreversible modifica-
tions of skeletal muscle proteins in a rat model of acute oxidative
stress. Biochim. Biophys. Acta 1792, 1185–1193
39. Shartava, A. et al. (1995) A posttranslational modification of
b-actin contributes to the slow dissociation of the spectrin-pro-
tein 4.1-actin complex of irreversibly sickled cells. J. Cell Biol.
128, 805–818
40. Farah, M.E. et al. (2011) Diverse protective roles of the actin
cytoskeleton during oxidative stress. Cytoskeleton 68, 340–354
41. Fiaschi, T. et al. (2006) Redox regulation of b-actin during integrin-
mediated cell adhesion. J. Biol. Chem. 281, 22983–22991
42. Dalle-Donne, I. et al. (2002) Methionine oxidation as a major
cause of the functional impairment of oxidized actin. Free Radic.
Biol. Med. 32, 927–937
43. Zhan, X. and Desiderio, D.M. (2004) The human pituitary nitro-
proteome: detection of nitrotyrosyl-proteins with two-dimensional
western blotting, and amino acid sequence determination with
mass spectrometry. Biochem. Biophys. Res. Commun. 325,
1180–1186
44. Xu, Q. et al. (2017) Redox regulation of the actin cytoskeleton and
its role in the vascular system. Free Radic. Biol. Med. 109, 84–107
45. Dalle-Donne, I. et al. (2007) Actin Cys374 as a nucleophilic target
of a,b-unsaturated aldehydes. Free Radic. Biol. Med. 42, 583–
598
46. Wong, S.W. et al. (2015) H2O2 exposure affects myotube stiffness
and actin filament polymerization. Ann. Biomed. Eng. 43, 1178–
1188
47. Castro, J.P. et al. (2012) Carbonylation of the cytoskeletal protein
actin leads to aggregate formation. Free Radic. Biol. Med. 53,
916–925
48. Hung, R.J. et al. (2011) Direct redox regulation of F-actin assem-
bly and disassembly by Mical. Science 334, 1710–1713
49. Hung, R.J. et al. (2013) SelR reverses Mical-mediated oxidation of
actin to regulate F-actin dynamics. Nat. Cell Biol. 15, 1445–1454
50. Lee, B.C. et al. (2013) MsrB1 and MICALs regulate actin assem-
bly and macrophage function via reversible stereoselective methi-
onine oxidation. Mol. Cell 51, 397–404
51. McDonald, C.A. et al. (2013) Actin stimulates reduction of the
MICAL-2 monooxygenase domain. Biochemistry 52, 6076–6084
52. Grintsevich, E.E. et al. (2017) Catastrophic disassembly of actin
filaments via Mical-mediated oxidation. Nat. Commun. 8, 2183
53. Wang, X.D. et al. (2015) TCR-induced SUMOylation of the kinase
PKC-u controls T cell synapse organization and T cell activation.
Nat. Immunol. 16, 1195–1203
54. Garcia-Ortiz, A. et al. (2017) eNOS S-nitrosylates b-actin on
Cys374 and regulates PKC-u at the immune synapse by impairing
actin binding to profilin-1. PLoS Biol. 15, e2000653
55. Bertling, E. et al. (2016) Actin tyrosine-53-phosphorylation in
neuronal maturation and synaptic plasticity. J. Neurosci. 36,
5299–5313
56. Olguin-Albuerne, M. and Moran, J. (2015) ROS produced by
NOX2 control in vitro development of cerebellar granule neurons
development. ASN Neuro 7, 1759091415578712
57. Munnamalai, V. et al. (2014) Bidirectional interactions between
NOX2-type NADPH oxidase and the F-actin cytoskeleton in neu-
ronal growth cones. J. Neurochem. 130, 526–540
58. Wang, J. et al. (2017) Arginyltransferase ATE1 is targeted to the
neuronal growth cones and regulates neurite outgrowth during
brain development. Dev. Biol. 430, 41–51
59. Kwon, Y.T. et al. (2002) An essential role of N-terminal arginylation
in cardiovascular development. Science 297, 96–99
60. Kurosaka, S. et al. (2010) Arginylation-dependent neural crest cell
migration is essential for mouse development. PLoS Genet. 6,
e1000878Trends in Biochemical Sciences, June 2019, Vol. 44, No. 6 515
61. Li, M.M. et al. (2013) ALKBH4-dependent demethylation of actin
regulates actomyosin dynamics. Nat. Commun. 4, 1832
62. Fremont, S. et al. (2017) Oxidation of F-actin controls the terminal
steps of cytokinesis. Nat. Commun. 8, 1–16
63. Yoon, J. et al. (2017) Amplification of F-actin disassembly and
cellular repulsion by growth factor signaling. Dev. Cell 42, 117–
129
64. Yoon, J. and Terman, J.R. (2018) Common effects of attractive
and repulsive signaling: further analysis of Mical-mediated F-actin
disassembly and regulation by Abl. Commun. Integr. Biol. 11,
e1405197
65. Yoon, J. and Terman, J.R. (2018) MICAL redox enzymes and
actin remodeling: new links to classical tumorigenic and cancer
pathways. Mol. Cell. Oncol. 5, e1384881
66. Lundquist, M.R. et al. (2014) Redox modification of nuclear actin
by MICAL-2 regulates SRF signaling. Cell 156, 563–576
67. Hofmann, W.A. et al. (2009) SUMOylation of nuclear actin. J. Cell
Biol. 186, 193–200
68. Uda, M. et al. (2015) Sumoylated a-skeletal muscle actin in the
skeletal muscle of adult rats. Mol. Cell. Biochem. 409, 59–66
69. Choudhary, C. et al. (2009) Lysine acetylation targets protein
complexes and co-regulates major cellular functions. Science
325, 834–840
70. Foster, D.B. et al. (2013) The cardiac acetyl-lysine proteome.
PLoS One 8, e67513
71. Viswanathan, M.C. et al. (2015) Pseudo-acetylation of K326 and
K328 of actin disrupts Drosophila melanogaster indirect flight
muscle structure and performance. Front. Physiol. 6, 116
72. Jain, R.K. et al. (2012) Nemaline myopathy with stiffness and
hypertonia associated with an ACTA1 mutation. Neurology 78,
1100–1103
73. Rubenstein, P.A. and Wen, K.K. (2014) Insights into the effects of
disease-causing mutations in human actins. Cytoskeleton 71,
211–229
74. Rai, R. et al. (2016) Arginyltransferase suppresses cell tumori-
genic potential and inversely correlates with metastases in human
cancers. Oncogene 35, 4058–4068
75. Forbes, S.A. et al. (2017) COSMIC: somatic cancer genetics at
high-resolution. Nucl. Acids Res. 45, D777–D783
76. Loria, R. et al. (2015) Sema6A and Mical1 control cell growth and
survival of BRAFV600E human melanoma cells. Oncotarget 6,
2779–2793
77. Deng, W. et al. (2016) MICAL1 controls cell invasive phenotype
via regulating oxidative stress in breast cancer cells. BMC Cancer
16, 489
78. Deng, W. et al. (2018) MICAL1 facilitates breast cancer cell
proliferation via ROS-sensitive ERK/cyclin D pathway. J. Cell
Mol. Med. 22, 3108–3118
79. Mariotti, S. et al. (2016) MICAL2 is a novel human cancer gene
controlling mesenchymal to epithelial transition involved in cancer
growth and invasion. Oncotarget 7, 1808–1825
80. Zhang, F.L. et al. (2010) Differential arginylation of actin isoforms is
regulated by coding sequence-dependent degradation. Science
329, 1534–1537
81. Xu, T. et al. (2009) Identification of N-terminally arginylated proteins
and peptides by mass spectrometry. Nat. Protoc. 4, 325–332516 Trends in Biochemical Sciences, June 2019, Vol. 44, No. 682. Wong, C.C.L. et al. (2007) Global analysis of posttranslational
protein arginylation. PLoS Biol. 5, 2231–2242
83. Rai, R. et al. (2008) Arginyltransferase regulates alpha cardiac
actin function, myofibril formation and contractility during heart
development. Development 135, 3881–3889
84. Kashina, A.S. (2006) Differential arginylation of actin isoforms: the
mystery of the actin N-terminus. Trends Cell Biol. 16, 610–615
85. Schutt, C.E. et al. (1993) The structure of crystalline profilin-
b-actin. Nature 365, 810–816
86. Malloy, L.E. et al. (2012) Thoracic aortic aneurysm (TAAD)-caus-
ing mutation in actin affects formin regulation of polymerization. J.
Biol. Chem. 287, 28398–28408
87. Bergeron, S.E. et al. (2011) Allele-specific effects of thoracic
aortic aneurysm and dissection a-smooth muscle actin mutations
on actin function. J. Biol. Chem. 286, 11356–11369
88. Jepsen, L. et al. (2016) Two deafness-causing actin mutations
(DFNA20/26) have allosteric effects on the actin structure. Bio-
phys. J. 111, 323–332
89. Laing, N.G. et al. (2009) Mutations and polymorphisms of the
skeletal muscle a-actin gene (ACTA1). Hum. Mutat. 30, 1267–
1277
90. Lee, C.Y. et al. (2016) Regulation of actin catch-slip bonds with a
RhoA-formin module. Sci. Rep. 6, 35058
91. Wen, K.K. et al. (2013) Importance of a Lys(113)-Glu(195) inter-
monomer ionic bond in F-actin stabilization and regulation by
yeast formins Bni1p and Bnr1p. J. Biol. Chem. 288, 19140–
19153
92. Oda, T. et al. (2009) The nature of the globular- to fibrous-actin
transition. Nature 457, 441–445
93. Aktories, K. et al. (2011) Actin as target for modification by
bacterial protein toxins. FEBS J. 278, 4526–4543
94. Aktories, K. et al. (1986) Botulinum C2 toxin ADP-ribosylates
actin. Nature 322, 390–392
95. Qu, Z. et al. (2018) Interaction of isolated cross-linked short actin
oligomers with the skeletal muscle myosin motor domain. FEBS
J. 285, 1715–1729
96. Toniti, W. et al. (2017) Crystal structure and structure-based
mutagenesis of actin-specific ADP-ribosylating toxin CPILE-a
as novel enterotoxin. PLoS One 12, e0171278
97. Lang, A.E. et al. (2017) Actin ADP-ribosylation at Threonine148 by
Photorhabdus luminescens toxin TccC3 induces aggregation of
intracellular F-actin. Cell Microbiol. Published online July 15,
2016. http://dx.doi.org/10.1111/cmi.12636
98. Lang, A.E. et al. (2010) Photorhabdus luminescens toxins ADP-
ribosylate actin and RhoA to force actin clustering. Science 327,
1139–1142
99. Heisler, D.B. et al. (2015) Actin-Directed Toxin. ACD toxin-pro-
duced actin oligomers poison formin-controlled actin polymeri-
zation. Science 349, 535–539
100. Kudryashova, E. et al. (2018) Actin cross-linking toxin is a
universal inhibitor of tandem-organized and oligomeric G-
actin binding proteins. Curr. Biol. 28, 1536–1547
101. Liu, Y. et al. (2017) A Legionella effector disrupts host cyto-
skeletal structure by cleaving actin. PLoS Pathog. 13,
e1006186
